Immuron Ltd - IMRN Company Short-Term Debt

Graphic logo of Immuron Ltd (IMRN)

Volatility, visible through the level of short obligations on the GURU.Markets chart time series, is smoothed out by the release of antibodies for gastrointestinal protection and global sales. Stable sales of products for tourists are based on customer trust, while business maturity is supported by the development of Travelan. Meanwhile, the value of 0.00 represents the current short-term debt metric for Immuron Limited (IMRN).

IMRN (immuron.com.au) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for Immuron Ltd (IMRN)

- price and consensus price forecast:
Price Chart Immuron Inc|IMRN - Fair Value Consensus
- market capitalization data:
Market Value Immuron Limited|IMRN - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Immuron|IMRN - Book Capitalization|Market Cap to Net Assets Ratio immuron.com.au|IMRN - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Immuron Limited|IMRN - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Immuron Inc|IMRN - Company Total Debt Obligations|Debt to Book Value Immuron Limited|IMRN - Amount of Long-Term Liabilities|Company Short-Term Debts Immuron
Initial company analysis:IMRN (immuron.com.au)
Brand item of Immuron Ltd

To conduct a high-quality asset selection, an investor must assess the risk of a cash gap by analyzing current liabilities that require settlement from the current cash flow. The total volume of such debts, reflected in the short-term debt chart, reveals whether the sales revenue from the Travelan drug is sufficient to service loans without compromising the development of the Immuron Limited biotech business.

Competitors of Immuron Limited (IMRN)

Company Short-Term Debt Phathom Pharmaceuticals, Inc. (PHAT)|TERN: Company Short-Term Loans and Borrowings|IRWD (ironwoodpharma.com) - Company Short-Term Debt|Curanex Pharmaceuticals (CURX) - Company Current Liabilities|EVOK (Evoke Pharma, Inc.) - Company Short-Term Debts|Company Short-Term Debts Entero (ENTO)|RedHill Biopharma (RDHL) - Company Current Liabilities|Company Short-Term Loans and Borrowings palisadebio.com (PALI)|JAGX (Jaguar Animal Health) - Company Short-Term Debts|Short-Term Indebtedness Biora Therapeutics, Inc BIOR|Company Short-Term Debts MORF (Morphic Holding, Inc.)